PharmExtracta Triumphs at NutraIngredients Awards Europe 2024: Two Category Wins for Crispact® and Sophy®
Two of our products, Crispact® and Sophy®, won at NutraIngredients Awards Europe 2024, showcasing their excellence in women’s health solutions.
Crispact® is recognized for its ability to restore the vaginal microbiome and support HPV clearance, while Sophy® effectively addresses PCOS symptoms with its potent Berberine Phytosome®.
Not One but Two Winners!
We are ecstatic to share that PharmExtracta has achieved remarkable success at the NutraIngredients Awards Europe 2024! Our innovative products, Crispact® and Sophy®, have not only been recognized as finalists but have also emerged as winners in their respective categories. This achievement highlights our unwavering commitment to advancing women’s health through cutting-edge, scientifically backed solutions.
Crispact® Wins Product of the Year: Microbiome Modulation
Crispact® has been awarded the prestigious title of Product of the Year in Microbiome Modulation. This recognition reflects the groundbreaking potential of Crispact® in the field of women’s health. Crispact® is a probiotic supplement specifically designed to address critical issues such as HPV, unexplained infertility, bacterial vaginosis (BV), thrush, and genitourinary infections.
Powered by the exclusive Lactobacillus crispatus M247 strain, Crispact® has shown significant clinical benefits, including the ability to clear HPV infections, normalize cervical cytology, and improve outcomes in Assisted Reproductive Technology (ART). Its unique formulation, which effectively restores vaginal microbiota, has set a new benchmark in the treatment of various infections.
What the Judges Said about Crispact®:
“Crispact® stood out for its clinically demonstrated potential to restore the vaginal microbiome, notably under the conditions of persistent HPV infections and bacterial vaginosis. This innovative oral probiotic with a vaginal probiotic bacterium extends the range of solutions for women’s health.”
Sophy® Claims Product of the Year: Botanical
We are also proud to announce that Sophy® has been honored as the Product of the Year in the Botanical category. This award recognizes Sophy® as a beacon of hope for women dealing with Polycystic Ovary Syndrome (PCOS). Formulated with Berberine Phytosome®, Sophy® addresses a wide range of PCOS symptoms, including irregular menstrual cycles, infertility, ovarian polycystosis, and acne, within just three months of treatment.
Sophy®’s enhanced bioavailability makes it ten times more effective than traditional berberine, ensuring that each 550 mg tablet delivers maximum therapeutic impact. Supported by extensive clinical trials, Sophy® provides real, tangible benefits, empowering women with PCOS to lead healthier lives.
What the Judges Said about Sophy®:
“For the judges, Sophy® had the ‘X-factor’ in serving the often-overlooked condition of PCOS. The research submitted was thorough, conducted on the finished product, and showed real results in women diagnosed with PCOS.”
Join Us at CPHI Milan – Stand 10F27
We invite you to join us at CPHI Milan to celebrate our wins and explore these award-winning products firsthand. Visit us at Stand 10F27 to discover how Crispact® and Sophy® are revolutionizing women’s health and setting new standards in the nutraceutical industry.
Mark your calendars and don’t miss the opportunity to learn more about our solutions!
